David Goldgar

发表

Genome-wide scan reveals association of psoriasis with IL-23 and NFB pathways

Pui-Yan Kwok, Sampath Prahalad, Dafna Gladman, 2016 .

Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.

Andrej Sali, Rachel Karchin, Rebecca Sutphen, 2007, Cancer research.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Mads Thomassen, Nina Ditsch, Vijai Joseph, 2012, Breast Cancer Research.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Mads Thomassen, Nina Ditsch, Dieter Niederacher, 2009, Human molecular genetics.

Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

Nazneen Rahman, Carel Meijers, Julian Peto, 2002, Nature Genetics.

Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families

Jun Li, Irene L Andrulis, Kum Kum Khanna, 2017, Breast Cancer Research and Treatment.

Haplotype Tagging Single Nucleotide Polymorphisms and Association Studies

John S. Witte, J. Witte, D. Stram, 2003, Human Heredity.

Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways

Pui-Yan Kwok, Sampath Prahalad, Yun Li, 2008, Nature Genetics.

Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations

Soo-Hwang Teo, S. Teo, W. Newman, 2012, European Journal of Human Genetics.

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

Kenneth Offit, Jeffery P. Struewing, Lawrence C. Brody, 1996, Nature Genetics.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Päivi Heikkilä, Mads Thomassen, Stephen Fox, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

Elisabeth Cardis, Susan Peock, Joan Paterson, 2012, BMJ : British Medical Journal.

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

Gunnar Rätsch, Brian Craft, David Haussler, 2018, PLoS genetics.

Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool

Jack Cuzick, Gord Glendon, Mary Beth Terry, 2019, JNCI cancer spectrum.

10-year performance of four models of breast cancer risk: a validation study.

Gord Glendon, Mary Beth Terry, John L Hopper, 2019, The Lancet. Oncology.

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

Kenneth Offit, Larry Norton, Heather Hampel, 1996, Nature Genetics.